Dachaigh › Ailseachadh nan Sgamhan › Kentucky › Lexington
Sgrùdaidhean clionaigeach Ailseachadh nan Sgamhan ann an Lexington, KY
Tha 18 sgrùdaidhean airson Ailseachadh nan Sgamhan a’ lorg phàirtichean aig làraichean ann agus timcheall air Lexington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
A’ fastadhÌre 3
- University of Kentucky/Markey Cancer Center, Lexington
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
A’ fastadhÌre 3
- Baptist Health Lexington, Lexington
- Baptist Health Hamburg, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
A’ fastadhÌre 2
- University of Kentucky Chandler Medical Center ( Site 0019), Lexington
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
A’ fastadhÌre 2/3
- Baptist Health Lexington, Lexington
- University of Kentucky Chandler Medical Center, Lexington
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A’ fastadhÌre 2/3
- Baptist Health Lexington, Lexington
- University of Kentucky Chandler Medical Center (UKCMC) - Markey Cancer Center (Lucille P. Markey Cancer Center), Lexington
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
A’ fastadhÌre 1/2
- University of Kentucky/Markey Cancer Center, Lexington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A’ fastadhÌre 3
- CHI Saint Joseph Cancer Center - East, Lexington
- University of Kentucky Chandler Medical Center, Lexington
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
A’ fastadhÌre 2
- University of Kentucky ( Site 0019), Lexington
EXoPERT EMERALD Clinical Study
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Lexington VA Healthcare System, Lexington
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- University of Kentucky/Markey Cancer Center, Lexington
Pathways, a Hope Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life During Advanced Lung Cancer Treatment
A’ fastadh
- University of Kentucky, Lexington
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2/3
- University of Kentucky/Markey Cancer Center, Lexington
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- University of Kentucky/Markey Cancer Center, Lexington
Precision Lung Cancer Survivorship Care Intervention
A’ fastadh
- Markey Cancer Center, Lexington
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A’ fastadhÌre 1
- University of Kentucky Markey Cancer Center, Lexington
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- Baptist Lexington, Lexington
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
A’ fastadhSgrùdadh amharc
- Lexington VA Health Care System, Lexington
Sgrùdaidhean Ailseachadh nan Sgamhan ann am bailtean eile
- Houston, TX78 sgrùdaidhean
- Boston, MA62 sgrùdaidhean
- New York City, NY60 sgrùdaidhean
- Los Angeles, CA45 sgrùdaidhean
- Arlington, VA41 sgrùdaidhean
- Washington, DC41 sgrùdaidhean
- Chicago, IL41 sgrùdaidhean
- Baltimore, MD40 sgrùdaidhean
- Nashville, TN40 sgrùdaidhean
- St. Louis, MO39 sgrùdaidhean
- Columbus, OH37 sgrùdaidhean
- Philadelphia, PA36 sgrùdaidhean
Sgrùdaidhean eile ann an Lexington
- Aillse Sgamhain Neo-chealla-beag23 sgrùdaidhean
- Cancer Ovarian16 sgrùdaidhean
- Aillse Prostata14 sgrùdaidhean
- Aillse (gach seòrsa)14 sgrùdaidhean
- Aillse a' bhroilleach14 sgrùdaidhean
- Ailse metastatach11 sgrùdadh
- Aillse colorectal11 sgrùdadh
- Fàilligeadh a' Chridhe11 sgrùdadh
- Melanoma10 sgrùdaidhean
- Leukemia myeloid geur10 sgrùdaidhean
- Obesity10 sgrùdaidhean
- Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil9 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.